1. Conjugates of methionine γ-lyase with polysialic acid: Two approaches to antitumor therapy.
- Author
-
Morozova E, Anufrieva N, Koval V, Lesnova E, Kushch A, Timofeeva V, Solovieva A, Kulikova V, Revtovich S, and Demidkina T
- Subjects
- Animals, Antineoplastic Agents therapeutic use, Carbon-Sulfur Lyases metabolism, Carbon-Sulfur Lyases pharmacokinetics, Carbon-Sulfur Lyases pharmacology, Cell Line, Tumor, Female, Humans, Kinetics, MCF-7 Cells, Mice, Mice, Inbred BALB C, Neoplasms therapy, Sialic Acids pharmacology, Sialic Acids therapeutic use, Antineoplastic Agents pharmacology, Carbon-Sulfur Lyases chemistry, Neoplasms drug therapy, Sialic Acids chemistry
- Abstract
The methionine dependence is a well known phenomenon in metabolism of cancer cells. Methionine γ-lyase (EC 4.4.1.11, MGL) catalyzes the γ-elimination reaction of L-methionine and thus could effectively inhibit the growth of malignant cells. Recently we have demonstrated that the mutant form of the enzyme C115H MGL can be used as a component of the pharmacological pair enzyme/S-(allyl/alkyl)-L-cysteine sulfoxides to yield thiosulfinates in situ. Thiosulfinates were shown to be toxic to various cancer cell lines. Therefore the application of the enzyme in enzyme pro-drug therapy may be promising. The conjugates of MGL and C115H MGL with polysialic acid were obtained and their kinetic and pharmacokinetic parameters were determined. The formation of polysialic shell around the enzyme was confirmed by atomic force microscopy. The half-life of conjugated enzymes increased 3-6 times compared to the native enzyme. The cytotoxic effect of conjugated MGL against methionine dependent cancer cell lines was increased two times compared to the values for the native enzymes. The anticancer efficiency of thiosulfinates produced by pharmacological pair C115H MGL/S-(allyl/alkyl)-L-cysteine sulfoxides was demonstrated in vitro. The results indicate that the conjugates of MGL with polysialic acid could be new antitumor drugs., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF